Polpharma Biologics is a biotechnology company that develops and manufactures biosimilar medicines to improve patient access to biopharmaceuticals. Operating from Switzerland, the company manages a broad portfolio of biosimilars targeting major therapeutic areas and collaborates with global biopharmaceutical partners to bring these treatments from concept to commercial supply.
Subscribe to see Polpharma Biologics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Polpharma Biologics is a biotech company headquartered in Poland. Xcout tracks 12 named people at Polpharma Biologics, including Anjan Selz (Chief Executive Officer).
6 more named people on record for Polpharma Biologics, with roles, board committees and tenure — see the full roster →
A few of Polpharma Biologics's closest competitors — see the full list of competitors and alternatives →
Mabion SA operates as a biotechnology company and Contract Development and Manufacturing Organization (CDMO) that provides services encompassing process development, analytics, and drug substance manufacturing. The company specializes in working with biologics such as biosimilars, antibodies, antibody-drug conjugates (ADCs), and recombinant therapeutic proteins to serve biopharmaceutical clients.
Alvotech specializes in the development and manufacturing of biosimilars to expand access to affordable biologic medicines for patients worldwide. The company utilizes a vertically integrated approach spanning from cell line development to fill and finish manufacturing.
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
Just-Evotec Biologics is a Seattle-based subsidiary of Evotec SE focused on innovative biologics drug discovery and manufacturing. Operating research and production facilities such as J.POD in Washington State, the company develops technologies for global access to biotherapeutics. It partners with major philanthropic organizations like the Gates Foundation to advance global health.
Abologix Sàrl is a biopharma and manufacturing company founded in 2018 and headquartered in Plan-les-Ouates, Geneva, Switzerland. It operates within the life sciences and antibodies sector.
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.